5-Amino-1MQ for fat loss: what the mouse studies actually show

What did @dr..alex.tatem actually say?

The creator described 5-amino-1MQ as a small molecule that blocks the NNMT enzyme, raises NAD+ levels, and pushes mitochondria to burn fat instead of store it. They called it "the stealthy fat burner" biohackers swear by, pitched its oral route as a selling point, and acknowledged that "solid human clinical trials? They don't exist yet." That last part matters more than the first three combined.

The video threads a familiar needle: introduce an exciting mechanism, cite animal data as proof of concept, then add a disclaimer that reads more like a legal footnote than genuine caution. The biochemistry explanation is simplified but not wildly off. The framing, however, positions "intriguing" and "legitimate scientific reasoning" as near-equivalents to "works in humans," which they are not.

Does the science back this up?

The NNMT-blocking mechanism is real and has been studied, but almost exclusively in rodent models. The human evidence trail is essentially empty right now, and that gap is not a technicality.

The foundational animal research comes from Hong et al. (2015, Nature Chemical Biology), which showed NNMT inhibition in mice led to reduced adiposity and improved metabolic markers. Follow-up work by Hay et al. (2020, Journal of Medicinal Chemistry) characterized 5-amino-1MQ specifically as a selective NNMT inhibitor and showed fat mass reductions in diet-induced obese mice. These are real, peer-reviewed studies. They are also mouse studies, and the metabolic physiology of a diet-induced obese rodent does not map cleanly onto a human trying to cut body fat.

The NAD+ connection is plausible on paper. NNMT consumes methyl groups that would otherwise support NAD+ precursor synthesis, so blocking it could theoretically support NAD+ availability. But "theoretically support" and "cranks up your mitochondrial fat burning engine" are very different claims. No published human trial has measured what 5-amino-1MQ actually does to NAD+ levels or fat oxidation in people.

What did they get wrong (or right)?

Credit where it is due: the creator was more honest than most peptide content on TikTok. Calling out the absence of human trials, flagging unknown dosing, and warning about sketchy vendor purity are all accurate and worth saying. That is genuinely better than the typical "biohacker-approved" sales pitch with no caveats.

What they got wrong, or at least glossed over, is the degree of uncertainty. Saying 5-amino-1MQ has "legitimate scientific reasoning behind its fat-burning potential" implies a more established evidence base than two rodent studies and a pile of Reddit posts. The phrase "impressive reductions in fat mass" applied to mice sounds compelling but tells you almost nothing about what happens in a 180-pound human with a functioning gut, liver metabolism, and years of dietary history.

They also describe NNMT as something that "normally slows down your metabolism and promotes fat storage," which flattens a more complex biology. NNMT plays roles in inflammation, cancer biology, and cellular methylation that are not simply "bad." Blocking it system-wide in humans may not be a clean intervention.

What should you actually know?

5-amino-1MQ is a research chemical, not a regulated supplement or approved therapeutic. The absence of FDA approval is not a bureaucratic inconvenience; it means no required safety trials, no standardized dosing, and no manufacturing oversight on products being sold right now.

The creator's point about sourcing is the most practically important thing in the video. Compounds sold through gray-market peptide vendors have been independently tested and found to contain incorrect concentrations, contaminants, or entirely different substances. A 2023 analysis by Venhuis et al. (Drug Testing and Analysis) of online peptide products found significant purity and labeling discrepancies across samples. That problem is not unique to 5-amino-1MQ.

Long-term effects of NNMT inhibition in humans are genuinely unknown. Given NNMT's roles outside of fat metabolism, including in certain cancer pathways, the idea of chronically suppressing it without clinical trial data should give any thoughtful person pause. "Cutting-edge can also mean we have no idea what the long-term effects are" is the truest thing said in this video, and it deserved more than a closing line.